unknown
Stage
4
Investors
About
Xellia is a global pharmaceutical company specializing in the production of fermentation-based non-beta-lactam anti-infective active pharmaceutical ingredients (APIs) and finished dosage forms, supplying over 500 pharmaceutical companies in 80 countries.
Explore Xellia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.